the partners

news

  • 2019/07/12

    With issue of the 2nd EPIICAL newsletter, we are pleased to announce that a poster on the CARMA study has been accepted for a presentation at both the 10th International AIDS Society 2019 Conference on HIV Science and pre-meeting: ‘2019 HIV & HBV Cure Forum’.

    read more
  • 2019/05/13

    With the EPIICAL project being a hive of activity over the last year, we have collected a selection of contributions, stories and articles to bring you the very first edition of the EPIICAL newsletter!

    read more
  • 2019/05/10

    Stories by patients and their families: “DOMILIQUE – the 2nd patient of the EARTH study” by Maria Lain

    read more

publications

  • Human Immunodeficiency Virus (HIV) – Antibody Repertoire Estimates Reservoir Size and Time of Antiretroviral Therapy Initiation in Virally Suppressed Perinatally HIV-Infected Children

    2018/09/04

    Background. Assays to estimate human immunodeficiency virus (HIV) reservoir size require large amounts of blood, which represents a drawback especially […]

    read more

  • Early and Highly Suppressive ART are Main Factors Associated with Low Viral Reservoir in European Perinatally HIV Infected Children

    2018/06/26

    Future strategies aiming to achieve HIV-1 remission are likely to target individuals with small reservoir size. We retrospectively investigated factors associated with HIV-1 DNA levels in European, perinatally HIV-infected children starting ART <6 months of age.

    read more

  • Report from the First EPIICAL General Assembly meeting, 9–11 November 2017, Rome, Italy

    2018/01/22

    The first EPIICAL General Assembly meeting was held in an atmosphere of growing optimism. Many novel and exciting proposals for HIV research studies were […]

    read more

  • The EPIICAL Project: an Emerging Global Collaboration to Investigate Immunotherapeutic Strategies in HIV-Infected Children

    2016/02/16

    The EPIICAL (Early-treated Perinatally HIV-infected Individuals: Improving Children’s Actual Life with Novel Immunotherapeutic Strategies) project arises from the firm belief […]

    read more